Equities
Health CareMedical Equipment and Services
  • Price (USD)112.03
  • Today's Change0.92 / 0.83%
  • Shares traded1.14m
  • 1 Year change+25.20%
  • Beta1.0294
Data delayed at least 15 minutes, as of Nov 22 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,603454618
Total Receivables, Net6336131,024
Total Inventory428405625
Prepaid expenses------
Other current assets, total3371,816174
Total current assets3,0013,2892,441
Property, plant & equipment, net665671753
Goodwill, net6,5346,4827,417
Intangibles, net3,0223,3774,063
Long term investments------
Note receivable - long term------
Other long term assets343311327
Total assets13,56514,13015,001
LIABILITIES
Accounts payable204273355
Accrued expenses278347460
Notes payable/short-term debt000
Current portion long-term debt/capital leases7224714.24
Other current liabilities, total246454394
Total current liabilities1,4501,5441,214
Total long term debt3,1783,9234,980
Total debt3,9004,3944,984
Deferred income tax9311,1091,480
Minority interest------
Other liabilities, total133170185
Total liabilities5,6926,7477,859
SHAREHOLDERS EQUITY
Common stock123126126
Additional paid-in capital2,4172,7532,761
Retained earnings (accumulated deficit)5,6094,9514,417
Treasury stock - common------
Unrealized gain (loss)(0.22)(0.04)(0.04)
Other equity, total(276)(447)(163)
Total equity7,8737,3837,141
Total liabilities & shareholders' equity13,56514,13015,001
Total common shares outstanding123126126
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.